Liraglutide Effectiveness in Type 2 Diabetes: Insights from a Real-World Cohort of Portuguese Patients

Liraglutide Effectiveness in Type 2 Diabetes: Insights from a Real-World Cohort of Portuguese Patients

Liraglutide is a long-acting glucagon-like peptide-1 receptor agonist prescribed to diabetic patients for glycaemic control. To understand the impact of liraglutide in the real-world setting, this study analysed its effects in a Portuguese cohort of Type 2 diabetes patients. This was an observationa...

Full description

Bibliographic Details
Main Authors: José Silva-Nunes, Edite Nascimento, Joana Louro, Jorge Dores, Teresa Laginha, Ana Gonçalves-Ferreira, Marta Alves, Selma B. Souto, Nelson Cunha, Elsa Pina, Rui Duarte, João Filipe Raposo
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Metabolites
Subjects:
liraglutide
real-world evidence
type 2 diabetes
glycaemic control
anthropometric parameters
cardiovascular risk factors
Online Access:https://www.mdpi.com/2218-1989/12/11/1121

Internet

https://www.mdpi.com/2218-1989/12/11/1121

Similar Items